Demonstrating the effectiveness of less restrictive care pathways for the management of patients treated with clozapine.

PubWeight™: 0.83‹?›

🔗 View Article (PMID 23897737)

Published in Australas Psychiatry on July 29, 2013

Authors

Sacha Filia1, Stuart Lee, Kelly Sinclair, Alyson Wheelhouse, Sally Wilkins, Anthony de Castella, Jayashri Kulkarni

Author Affiliations

1: Research Fellow, Monash Alfred Psychiatry Research Centre (MAPrc), Central Clinical School, Monash University and The Alfred Hospital, Melbourne, VIC, Australia.

Articles by these authors

Effects of aromatase inhibition on sexual function and well-being in postmenopausal women treated with testosterone: a randomized, placebo-controlled trial. Menopause (2006) 2.07

The effect of abdominal pain duration on the accuracy of diagnostic imaging for pediatric appendicitis. Ann Emerg Med (2012) 2.05

Women survivors of child abuse - don't ask, don't tell. Aust Fam Physician (2012) 2.01

Estrogen in severe mental illness: a potential new treatment approach. Arch Gen Psychiatry (2008) 1.78

Performance of ultrasound in the diagnosis of appendicitis in children in a multicenter cohort. Acad Emerg Med (2013) 1.74

Interrater reliability of clinical findings in children with possible appendicitis. Pediatrics (2012) 1.54

An analysis of functional neuroimaging studies of dorsolateral prefrontal cortical activity in depression. Psychiatry Res (2006) 1.53

Mechanisms of abnormal cardiac repolarization during insulin-induced hypoglycemia. Diabetes (2003) 1.50

Validation and refinement of a prediction rule to identify children at low risk for acute appendicitis. Arch Pediatr Adolesc Med (2012) 1.49

Funding for mental health research: the gap remains. Med J Aust (2011) 1.38

Gender differences in schizophrenia and first-episode psychosis: a comprehensive literature review. Schizophr Res Treatment (2012) 1.37

Transcranial magnetic stimulation in the treatment of depression: a double-blind, placebo-controlled trial. Arch Gen Psychiatry (2003) 1.36

A pilot study of hormone modulation as a new treatment for mania in women with bipolar affective disorder. Psychoneuroendocrinology (2005) 1.36

A randomized trial of rTMS targeted with MRI based neuro-navigation in treatment-resistant depression. Neuropsychopharmacology (2009) 1.16

Dehydroepiandrosterone sulfate levels are associated with more favorable cognitive function in women. J Clin Endocrinol Metab (2007) 1.14

A randomized, controlled trial of sequential bilateral repetitive transcranial magnetic stimulation for treatment-resistant depression. Am J Psychiatry (2006) 1.13

A randomized trial of low-frequency right-prefrontal-cortex transcranial magnetic stimulation as augmentation in treatment-resistant major depression. Int J Neuropsychopharmacol (2006) 1.08

An fMRI study of prefrontal brain activation during multiple tasks in patients with major depressive disorder. Hum Brain Mapp (2008) 1.07

Australian Schizophrenia Care and Assessment Programme: real-world schizophrenia: economics. Aust N Z J Psychiatry (2007) 1.06

A double-blind sham-controlled trial of repetitive transcranial magnetic stimulation in the treatment of refractory auditory hallucinations. J Clin Psychopharmacol (2005) 1.02

Piloting the effective therapeutic dose of adjunctive selective estrogen receptor modulator treatment in postmenopausal women with schizophrenia. Psychoneuroendocrinology (2010) 1.02

A prospective study of the impact of smoking on outcomes in bipolar and schizoaffective disorder. Compr Psychiatry (2010) 0.98

A transcranial magnetic stimulation study of inhibitory deficits in the motor cortex in patients with schizophrenia. Psychiatry Res (2002) 0.97

What is needed to deliver collaborative care to address comorbidity more effectively for adults with a severe mental illness? Aust N Z J Psychiatry (2012) 0.94

Reduced neural activity of the prefrontal cognitive control circuitry during response inhibition to negative words in people with schizophrenia. J Psychiatry Neurosci (2012) 0.91

Naturalistic study of the use of transcranial magnetic stimulation in the treatment of depressive relapse. Aust N Z J Psychiatry (2006) 0.91

A longitudinal study of patient- and observer-rated quality of life in schizophrenia. Psychiatry Res (2003) 0.90

Repetitive transcranial magnetic stimulation reveals abnormal plastic response to premotor cortex stimulation in schizophrenia. Biol Psychiatry (2004) 0.88

Estrogens and gonadal function in schizophrenia and related psychoses. Curr Top Behav Neurosci (2011) 0.88

Coronary heart disease risk reduction intervention among overweight smokers with a psychotic disorder: pilot trial. Aust N Z J Psychiatry (2009) 0.87

A study of the effectiveness of bilateral transcranial magnetic stimulation in the treatment of the negative symptoms of schizophrenia. Brain Stimul (2007) 0.86

A randomized trial of the anti-depressant effects of low- and high-frequency transcranial magnetic stimulation in treatment-resistant depression. Depress Anxiety (2009) 0.86

Transitioning patients taking clozapine from the public to private/GP shared-care setting: barriers and criteria. Aust N Z J Psychiatry (2012) 0.85

Estrogens and men with schizophrenia: is there a case for adjunctive therapy? Schizophr Res (2010) 0.85

Motor cortical excitability and clinical response to rTMS in depression. J Affect Disord (2004) 0.85

'Stroke a Chord': the effect of singing in a community choir on mood and social engagement for people living with aphasia following a stroke. NeuroRehabilitation (2013) 0.84

A preliminary fMRI study of the effects on cortical activation of the treatment of refractory auditory hallucinations with rTMS. Psychiatry Res (2007) 0.84

The treatment of recurring auditory hallucinations in schizophrenia with rTMS. World J Biol Psychiatry (2006) 0.84

Preliminary findings from the National Register of Antipsychotic Medication in Pregnancy. Aust N Z J Psychiatry (2008) 0.83

Vestibular insights into cognition and psychiatry. Brain Res (2013) 0.83

A transcranial magnetic stimulation study of abnormal cortical inhibition in schizophrenia. Psychiatry Res (2003) 0.82

Treatment and outcomes of an Australian cohort of outpatients with bipolar I or schizoaffective disorder over twenty-four months: implications for clinical practice. BMC Psychiatry (2012) 0.82

Priming stimulation enhances the effectiveness of low-frequency right prefrontal cortex transcranial magnetic stimulation in major depression. J Clin Psychopharmacol (2008) 0.82

Hormone modulation: a novel therapeutic approach for women with severe mental illness. Aust N Z J Psychiatry (2008) 0.82

Observation versus self-report: validation of a consumer food behavior questionnaire. J Food Prot (2004) 0.81

A functional magnetic resonance imaging study of the effects of low frequency right prefrontal transcranial magnetic stimulation in depression. J Clin Psychopharmacol (2007) 0.81

Gender-sensitive mental health care. Australas Psychiatry (2009) 0.81

The relationship of changes in leptin, neuropeptide Y and reproductive hormones to antipsychotic induced weight gain. Hum Psychopharmacol (2003) 0.81

The sick role, illness cognitions and outcomes in bipolar disorder. J Affect Disord (2012) 0.81

Amoxapine in schizophrenia: a negative double-blind controlled trial. J Clin Psychopharmacol (2004) 0.81

Estradiol treatment and its interaction with the cholinergic system: effects on cognitive function in healthy young women. Horm Behav (2008) 0.81

The role of oestrogen and other hormones in the pathophysiology and treatment of schizophrenia. Schizophr Res Treatment (2012) 0.80

A study of the effects of lorazepam and dextromethorphan on the response to cortical 1 Hz repetitive transcranial magnetic stimulation. Neuroreport (2005) 0.80

EVestG: a diagnostic measure for schizophrenia. Conf Proc IEEE Eng Med Biol Soc (2008) 0.80

Monitoring the safe use of clozapine: a consensus view from Victoria, Australia. CNS Drugs (2007) 0.80

Vulnerable populations and multicentred research. Int J Ment Health Nurs (2009) 0.79

Testosterone improves antidepressant-emergent loss of libido in women: findings from a randomized, double-blind, placebo-controlled trial. J Sex Med (2014) 0.79

Testosterone aromatization and cognition in women: a randomized, placebo-controlled trial. Menopause (2006) 0.78

A comparison of ziprasidone and risperidone in the long-term treatment of schizophrenia: a 44-week, double-blind, continuation study. Can J Psychiatry (2009) 0.78

A study of the effectiveness of high-frequency left prefrontal cortex transcranial magnetic stimulation in major depression in patients who have not responded to right-sided stimulation. Psychiatry Res (2009) 0.78

What factors determine whether a woman becomes depressed during the perimenopause? Arch Womens Ment Health (2012) 0.78

Depressive, positive, negative and parkinsonian symptomsin schizophrenia. Aust N Z J Psychiatry (2002) 0.77

The perceived risks and benefits of quitting in smokers diagnosed with severe mental illness participating in a smoking cessation intervention: gender differences and comparison to smokers without mental illness. Drug Alcohol Rev (2013) 0.77

Factors associated with depression during the perimenopausal transition. Womens Health Issues (2013) 0.77

Psychiatrists' awareness of partial and nonadherence to antipsychotic medication in schizophrenia: results from an Asia-Pacific survey. Neuropsychiatr Dis Treat (2013) 0.77

Sequential behavioral treatment of smoking and weight control in bipolar disorder. Transl Behav Med (2012) 0.76

Managing psychosis in pregnancy. Aust N Z J Psychiatry (2007) 0.76

Sensitivity, specificity, and predictive power of the "Brief Risk-resilience Index for SCreening," a brief pan-diagnostic web screen for emotional health. Brain Behav (2012) 0.76

Oestrogen: an overlooked mediator in the neuropsychopharmacology of treatment response? Int J Neuropsychopharmacol (2010) 0.76

Hormonal therapies for new onset and relapsed depression during perimenopause. Maturitas (2012) 0.76

The potential role of ultrasound in differentiating solid and cystic swellings of the true vocal fold. J Voice (2004) 0.76

Breastfeeding and psychotropic medications. Lancet (2013) 0.76

The cost of relapse in schizophrenia and schizoaffective disorder. Australas Psychiatry (2009) 0.76

Biological basis of sex differences in psychopharmacology. Preface. Curr Top Behav Neurosci (2011) 0.75

Psychotropic medication in pregnancy. Med J Aust (2013) 0.75

Primary healthcare practitioners' screening practices and attitudes towards women survivors of child abuse. Ment Health Fam Med (2012) 0.75

Oestrogen and neuroprotection. Aust N Z J Psychiatry (2011) 0.75

Psychometric properties of a scale to measure investment in the sick role: the Illness Cognitions Scale. J Eval Clin Pract (2010) 0.75

Female sexual dysfunction in psychiatry. Aust N Z J Psychiatry (2012) 0.75

Raloxifene may have further benefits in women on hemodialysis. Int J Endocrinol Metab (2012) 0.75

Response to Anandarajan et al.: Manic exacerbation induced by nicotine patch. Aust N Z J Psychiatry (2012) 0.75

Measuring the impacts of seclusion on psychiatry inpatients and the effectiveness of a pilot single-session post-seclusion counselling intervention. Int J Ment Health Nurs (2013) 0.75

Determining the efficacy and tolerance of quetiapine extended release for the management of psychosis and accompanying acute behavioral disturbance in adult acute psychiatry. Ann Clin Psychiatry (2012) 0.75

Psychosis and gender. Schizophr Res Treatment (2012) 0.75

Major depression and electrovestibulography. World J Biol Psychiatry (2015) 0.75

To a broader concept of remission: rating the health-related quality of life in bipolar disorder. J Affect Disord (2013) 0.75